IB 
Union Calendar No. 196 
112TH CONGRESS 
1ST SESSION H. R. 1254 
[Report No. 112–295, Parts I and II] 
To amend the Controlled Substances Act to place synthetic drugs in Schedule 
I. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 30, 2011 
Mr. DENT (for himself, Mr. MEEHAN, Mr. MARINO, Mr. PLATTS, Mr. 
BARLETTA, Mr. CUELLAR, Mrs. EMERSON, Mrs. BIGGERT, Mr. LATOU-
RETTE, Mr. GIBSON, Mr. STIVERS, and Mr. REED) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committee on the Judiciary, for a period 
to be subsequently determined by the Speaker, in each case for consider-
ation of such provisions as fall within the jurisdiction of the committee 
concerned 
NOVEMBER 22, 2011 
Reported from the Committee on Energy and Commerce with an amendment 
[Strike out all after the enacting clause and insert the part printed in italic] 
NOVEMBER 22, 2011 
Additional sponsors: Mr. HOLDEN, Mr. BOSWELL, Mr. LATHAM, Mr. 
LOEBSACK, Mr. DEFAZIO, Mr. DOLD, Mr. LANCE, Mr. MURPHY of Penn-
sylvania, Mrs. BONO MACK, Mr. MICHAUD, Ms. PINGREE of Maine, and 
Mr. GOWDY 
NOVEMBER 22, 2011 
Reported from the Committee on the Judiciary with an amendment, com-
mitted to the Committee of the Whole House on the State of the Union, 
and ordered to be printed 
[Strike out all after the enacting clause and insert the part printed in boldface roman] 
[For text of introduced bill, see copy of bill as introduced on March 30, 2011] 
VerDate Mar 15 2010 
22:36 Nov 22, 2011
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H1254.RH
H1254
mstockstill on DSK4VPTVN1PROD with BILLS
A BILL 
To amend the Controlled Substances Act to place synthetic 
drugs in Schedule I. 
VerDate Mar 15 2010 
22:36 Nov 22, 2011
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6652
E:\BILLS\H1254.RH
H1254
mstockstill on DSK4VPTVN1PROD with BILLS
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Synthetic Drug Control 
Act of 2011’’. 
SEC. 2. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I 
OF THE CONTROLLED SUBSTANCES ACT. 
(a) CANNABIMIMETIC AGENTS.—Schedule I, as set 
forth in section 202(c) of the Controlled Substances Act (21 
U.S.C. 812(c)) is amended by adding at the end the fol-
lowing: 
‘‘(d)(1) Unless specifically exempted or unless listed in 
another schedule, any material, compound, mixture, or 
preparation 
which 
contains 
any 
quantity 
of 
cannabimimetic agents, or which contains their salts, iso-
mers, and salts of isomers whenever the existence of such 
salts, isomers, and salts of isomers is possible within the 
specific chemical designation. 
‘‘(2) In paragraph (1): 
‘‘(A) The term ‘cannabimimetic agents’ means 
any substance that is a cannabinoid receptor type 1 
(CB1 receptor) agonist as demonstrated by binding 
studies and functional assays within any of the fol-
lowing structural classes: 
VerDate Mar 15 2010 
22:36 Nov 22, 2011
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6203
E:\BILLS\H1254.RH
H1254
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(i) 
2-(3-hydroxycyclohexyl)phenol 
with 
substitution at the 5-position of the phenolic ring 
by alkyl or alkenyl, whether or not substituted on 
the cyclohexyl ring to any extent. 
‘‘(ii) 
3-(1-naphthoyl)indole 
or 
3-(1- 
naphthylmethane)indole by substitution at the 
nitrogen atom of the indole ring, whether or not 
further substituted on the indole ring to any ex-
tent, whether or not substituted on the naphthoyl 
or naphthyl ring to any extent. 
‘‘(iii) 3-(1-naphthoyl)pyrrole by substi-
tution at the nitrogen atom of the pyrrole ring, 
whether or not further substituted in the pyrrole 
ring to any extent, whether or not substituted on 
the naphthoyl ring to any extent. 
‘‘(iv) 1-(1-naphthylmethylene)indene by sub-
stitution of the 3-position of the indene ring, 
whether or not further substituted in the indene 
ring to any extent, whether or not substituted on 
the naphthyl ring to any extent. 
‘‘(v) 3-phenylacetylindole or 3-benzoylindole 
by substitution at the nitrogen atom of the indole 
ring, whether or not further substituted in the 
indole ring to any extent, whether or not sub-
stituted on the phenyl ring to any extent. 
VerDate Mar 15 2010 
22:36 Nov 22, 2011
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6203
E:\BILLS\H1254.RH
H1254
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(B) Such term includes— 
‘‘(i) 
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3- 
hydroxycyclohexyl]-phenol (CP-47,497); 
‘‘(ii) 
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3- 
hydroxycyclohexyl]-phenol (cannabicyclohexanol 
or CP-47,497 C8-homolog); 
‘‘(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH- 
018 and AM678); 
‘‘(iv) 1-butyl-3-(1-naphthoyl)indole (JWH- 
073); 
‘‘(v) 1-hexyl-3-(1-naphthoyl)indole (JWH- 
019); 
‘‘(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naph-
thoyl)indole (JWH-200); 
‘‘(vii) 
1-pentyl-3-(2- 
methoxyphenylacetyl)indole (JWH-250); 
‘‘(viii) 
1-pentyl-3-[1-(4- 
methoxynaphthoyl)]indole (JWH-081); 
‘‘(ix) 
1-pentyl-3-(4-methyl-1-naph-
thoyl)indole (JWH-122); 
‘‘(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole 
(JWH-398); 
‘‘(xi) 
1-(5-fluoropentyl)-3-(1-naph-
thoyl)indole (AM2201); 
VerDate Mar 15 2010 
22:36 Nov 22, 2011
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6203
E:\BILLS\H1254.RH
H1254
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(xii) 
1-(5-fluoropentyl)-3-(2- 
iodobenzoyl)indole (AM694); 
‘‘(xiii) 
1-pentyl-3-[(4-methoxy)-ben-
zoyl]indole (SR-19 and RCS-4); 
‘‘(xiv) 
1-cyclohexylethyl-3-(2- 
methoxyphenylacetyl)indole (SR-18 and RCS-8); 
and 
‘‘(xv) 
1-pentyl-3-(2- 
chlorophenylacetyl)indole (JWH-203).’’. 
(b) OTHER DRUGS.—Schedule I of section 202(c) of 
the Controlled Substances Act (21 U.S.C. 812(c)) is amend-
ed in subsection (c) by adding at the end the following: 
‘‘(18) 4-methylmethcathinone (Mephedrone). 
‘‘(19) 3,4-methylenedioxypyrovalerone (MDPV). 
‘‘(20) 
3,4-methylenedioxymethcathinone 
(methylone). 
‘‘(21) Naphthylpyrovalerone (naphyrone). 
‘‘(22) 4-fluoromethcathinone (flephedrone). 
‘‘(23) 4-methoxymethcathinone (methedrone; Bk- 
PMMA). 
‘‘(24) Ethcathinone (N-Ethylcathinone). 
‘‘(25) 3,4-methylenedioxyethcathinone (ethylone). 
‘‘(26) 
Beta-keto-N-methyl-3,4- 
benzodioxyolybutanamine (butylone). 
‘‘(27) N,N-dimethylcathinone (metamfepramone). 
VerDate Mar 15 2010 
22:36 Nov 22, 2011
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6203
E:\BILLS\H1254.RH
H1254
mstockstill on DSK4VPTVN1PROD with BILLS